Abstract
OBJECTIVE. The objective of our study was to show the efficacy and safety of percutaneous ethanol ablation in managing recurrent primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1 (MEN1) after subtotal parathyroidectomy. CONCLUSION. Ethanol ablation is a viable alternative to reoperation for the management of recurrent primary hyperparathyroidism in patients with MEN1.
Original language | English (US) |
---|---|
Pages (from-to) | 1740-1744 |
Number of pages | 5 |
Journal | American Journal of Roentgenology |
Volume | 191 |
Issue number | 6 |
DOIs | |
State | Published - Dec 2008 |
Keywords
- Alcohol ablation
- Ethanol ablation
- Hypercalcemia
- Hyperparathyroidism
- Multiple endocrine neoplasia syndrome
- Parathyroid gland
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging